| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
L19
|
0.58 | 217.3M | 1.53 | 1.04 | 0.30 | 69.6% | 12.2% | 86 | 88 | 1.48 | +117.2% | 84 | 0.21 |
|
G50
|
0.73 | 136.2M | 2.50 | 1.29 | 1.53 | 14.4% | 11.8% | 79 | 60 | 1.48 | +76.7% | 80 | 0.33 |
|
40V
|
0.02 | 59.4M | — | 1.06 | — | -35.0% | 15.7% | 19 | 14 | 0.01 | -41.2% | 67 | 0.01 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.